학술논문
PO-425 Combined administration of anti-IL6 and anti-PD-L1 antibodies prevents ketogenic failure, reduces tumour progression, and increases overall survival in an autochthonous murine pancreatic cancer model
Document Type
Abstract
Author
Source
In ESMO Open 30 June-3 July 2018 3 Supplement 2:A397-A397
Subject
Language
ISSN
2059-7029